The pathway leading to the telltale sign of ALS, protein aggregation in the cytoplasm of motor neurons, has been revealed.
Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...
Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...
Trace Neuroscience, a startup spun out of Maze Therapeutics' pipeline, broke cover Tuesday morning with $101 million in ...
Trace Neuroscience launched on Tuesday to announce that it is developing a genetic treatment targeting UNC13A, a gene linked ...